Melanoma vax shows early promise; H7N9 deadlier than earlier outbreaks;

> A melanoma vaccine made up of dendritic cells has shown promise in a 12-person trial. Item

> A paper in The Lancet reports H7N9 is deadlier than both H5N1 and H1N1. Research

> Non-profit Sabin Vaccine Institute has formed the International Association of Immunization Managers. Release

> The CDC estimates influenza vaccines have prevented 13.6 million cases of flu over the past 6 years. News

> Researchers have used gold nanorods to deliver proteins to immune cells. Piece

> A vaccine shortage is hindering efforts to control a measles outbreak that has killed 500 children in Pakistan. Article

Suggested Articles

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.

In an effort to stop an Ebola outbreak that has claimed 2,200 lives at the Rwanda border, J&J is shipping 200,000 doses of its vaccine to the country.